Medical Marijuana
First Steps:
- The patient must register on the PA Medical Marijuana Patient Registry website at https://padohmmp.custhelp.com/app/login.
- The patient can then set up an appointment with one of our providers to obtain a medical marijuana certification. The patient must present a diagnosis and history that confirm one of the state’s listed qualifying conditions for medical marijuana to our providers.
- Once diagnosis is confirmed and certification is provided, the patient will complete their registration online and will pay $50 for their medical marijuana ID card.
- Patient can then visit a dispensary in their area with the ID card, to meet with dispensary staff and determine the optimal formulation for their diagnosis.
If you have any questions please email Patients@zabreckyinstitute.com for assistance.
Pricing:
Our pricing structure is as follows:
- First-time visit: $150.00. This includes evaluation of our intake form, verification of previously established diagnosis, and certification at the end of the visit.
- Proof of Medical History is required. Any documentation must clearly state your diagnosis. Example documentation includes an after-visit summary of your doctor's visit; a print-out of your diagnosis from a patient portal; imaging report; a note from any healthcare provider, PCP, specialist, or behavioral health counselor stating your diagnosis. Documentation does not have to be in-depth or recent.
- Renewal of Certification: $75.00
- First-time visit & Anxiety Diagnosis: $175.00. This includes evaluation of our intake form, diagnosis of anxiety, and certification at the end of the visit.
- Length of appointments: 15-20 minutes.
- Insurance accepted: No.
Conditions treated with medical marijuana include the following:
- Amyotrophic lateral sclerosis
- Anxiety disorders
- Autism
- Cancer; including remission therapy
- Crohn's disease
- Damage to the nervous tissue of the central nervous system (brain-spinal chord) with objective neurological indication of intractable spasticity, and other associated neuropathies
- Dyskinetic and spastic movement disorders
- Epilepsy
- Glaucoma
- HIV/AIDS
- Huntington's disease
- Inflammatory bowel disease
- Intractable seizures
- Multiple sclerosis
- Neurodegenerative diseases
- Neuropathies
- Opioid use disorder for which conventional therapeutic interventions are contraindicated or ineffective, or for which adjuctive therapy is indicated in combination with primary therapeutic interventions
- Parkinson's disease
- PTSD
- Severe chronic or intractable pain of neuropathic origin or severe chronic or intractable pain
- Sickle cell anemia
- Terminal illness
- Tourette syndrome